(ZY.3.02) Physics

Mechanics who specialize in more cutting-edge technology and composites are predicted to have an edge in the market going forward.
Biomechatronics (integrating biology, mechanics, and electronics) and related disciplines will create interventions that counter not only physical but also mental and cognitive disabilities.
3D printed electronics are already in use for smartphone manufacture and 2017 will see the next generation of printers powered by quantum mechanics to produce multilayer Printed Circuit Boards (PCBs).
Einstein's theory of relativity has a flaw according to British scientists who claim that their five-dimensional (5D) black rings (instead of round black holes) could enable singularities to be observed.
An international team of physicists is about to test a "sacrilegious" hypothesis about protons and the results could force a literal rewrite of nuclear physics textbooks.
The expansion in computing power gained by incorporating quantum mechanics principles into computing could prove to be as revolutionary to computer science as research in physics and electromagnetism has proved to modern electronics.
The particle physics experience in collaborative development of highly complex systems with large data volumes could be explored for adoption for use at light sources.
People will be suspicious of game mechanics being introduced into other areas of their lives especially in work and government contexts.
The permeation of game mechanics into everyday life and work will be a byproduct of social media.
A computer based on the rules of quantum mechanics could help crack problems that are currently unsolvable.
Global Drug-Device Combination Market is expected to grow at 7.5% CAGR in the forecast period of 2018-2025 to an estimated value of USD188.2 billion by the end of the year 2025, from its initial base value of USD105.4 billion in the base year of 2017.
The North American pharmaceutical & cosmetics industrial robots market is predicted to reach USD368.88 million in terms of the robotic system in 2025, growing by over 9.7% annually during the forecasted period from 2019-2025.
The Big Data Pharmaceutical Advertising Market regional market is projected to reach a valuation of USD1833.5 million by the end of the forecast period in 2023: The North American market holds a majority of the market share with approximately 42.3% under its name in 2015.
The global gastrointestinal drug market is expected to grow at CAGR of 4.8% during forecasted period 2017-2023.
Analysts expect the FDA to approve oral CGRPs next year from Biohaven Pharmaceutical and Allergan, potentially adding more competition to the therapeutic class.
With more similar drugs expected to reach the market in coming years, for a range of diseases and chronic conditions, the burden on health plans is likely to increase.
The expansion of the healthcare market has positively impacted the Auto-Injectors Market to a certain degree: The market will reach approximately USD6 billion by the year 2025.
Administering pricey specialty drugs in doctors' offices and patients' homes instead of US hospitals could reduce drug costs by $4 billion a year for insurance plans.
A bill to lower drug costs now under consideration in the Senate is projected to cut revenue from the pharmaceutical industry by $85 billion over the next decade if passed.
Next year it's predicted that total revenues from sales of cholesterol lowering statin drugs could reach US $1 trillion.
The biosimilars market is forecasted to reach US$23.6 billion by 2023 at a compound annual growth rate of 31.70%.
The CRISPR market in North America is expected to hold the largest share by 2027 due to strong possibilities of a growth trend in the biotechnology and pharmaceutical industries.
The global market for Cannabis technology was estimated at $14.5 billion in 2018 which is projected to grow exponentially at a CAGR of 33.17 percent and attain a market value of $107.67 billion by 2025.

See full forecast

Last updated: 18 February 2020